Treatment adherence in the Estonian postmenopausal hormone therapy (EPHT) trial [ISRCTN35338757]

Maturitas

Volumn 52, Issue 3-4, 2005, Pages 286-295

  Vorobjov, Sigrid ^a,b,c   Hovi, Sirpa Liisa ^d,e   Veerus, Piret ^a,c,d   Pisarev, Heti ^b   Rahu, Mati ^a,c   Hemminki, Elina ^e  

^a NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

^c Estonian Centre of Behavioral and Health Sciences   (Estonia)

^d UNIVERSITY OF TAMPERE   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Adherence; Postmenopausal hormone therapy; Randomised controlled trial

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CHILDBIRTH; CONTROLLED STUDY; DRUG SAFETY; DRUG WITHDRAWAL; ESTONIA; FEMALE; HEALTH EDUCATION; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; POSTMENOPAUSE; RISK ASSESSMENT; RISK FACTOR; SATISFACTION; SIDE EFFECT; SOCIOECONOMICS; TREATMENT OUTCOME;

AGE FACTORS; CONTRACEPTIVE AGENTS, FEMALE; EDUCATIONAL STATUS; ESTONIA; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LIFE STYLE; MARITAL STATUS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; PATIENT COMPLIANCE; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; SMOKING; TIME FACTORS;

EID: 27644598706     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.05.001     Document Type: Article

References (41)

1. L.M. Friedman, C.D. Furberg, and D.L. DeMets Fundamentals of clinical trials 3rd ed. 1998 Springer NY
2. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199-208.
3. S. Hulley, D. Grady, and T. Bush Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group JAMA 280 1998 605 613
4. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-33.
5. S.J. Pocock Clinical trials: a practical approach 1983 Wiley Chichester
6. P.A. Ganz, R. Day, and J. Costantino Compliance with quality of life data collection in the national surgical adjuvant breast and bowel project (NSABP) breast cancer prevention trial StatMed 17 1998 613 622
7. R.F. Reynolds, C.M. Obermeyer, A.M. Walker, and D. Guilbert Side effects and sociobehavioral factors associated with the discontinuation of hormone therapy in a Massachusetts health maintenance organization Menopause 8 2001 189 199
8. J.A. Cramer Overview of methods to measure and enhance patient compliance J.A. Cramer B. Spilker Patient compliance in medical practice and clinical trials 1991 Raven Press NY p. 3-10
9. J. Coope, and J. Marsh Can we improve compliance with long-term HRT? Maturitas 15 1992 151 158
10. B.J. Oddens, and M.J. Boulet Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance Obstet Gynecol 90 1997 269 277
11. P. Vestergaard, A.P. Hermann, and J. Gram Improving compliance with hormonal replacement therapy in primary osteoporosis prevention Maturitas 28 1997 137 145
12. R.F. Reynolds, A.M. Walker, C.M. Obermeyer, O. Rahman, and D. Guilbert Discontinuation of postmenopausal hormone therapy in a Massachusetts HMO J Clin Epidemiol 54 2001 1056 1064
13. L. Manzoli, P. Di Giovanni, and L. Del Duca Use of hormone replacement therapy in Italian women aged 50-70 years Maturitas 49 2004 241 251
14. I. Fistonic, C. Srecko, M. Fistonic, and I. Skegro Menopause in Croatia: socio-demographic characteristics, women's attitudes and source of information, compliance with HRT Maturitas 47 2004 91 98
15. M. Vickers, T. Meade, and J. Darbyshire WISDOM: history and early demise - was it inevitable? Climacteric 5 2002 317 325
16. E. Hemminki, S.-L. Hovi, and P. Veerus Blinding decreased recruitment in a prevention trial of postmenopausal hormone therapy J Clin Epidemiol 57 2004 1237 1243
17. S.R. Rapp, M.A. Espeland, and S.A. Shumaker Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial JAMA 289 20 2003 2663 2672
18. J.E. Manson, J. Hsia, and K.C. Johnson Estrogen plus progestin and the risk of coronary heart disease N Engl J Med 349 6 2003 523 534
19. S.A. Shumaker, C. Legault, and S.R. Rapp Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial JAMA 289 20 2003 2651 2662
20. V. Beral Million Women Study Collaborators Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419 427
21. J.S. Hurley, E.J. Frost, K.M. Trinkaus, M.C. Buatti, and K.E. Emmett Relationship of compliance with hormone replacement therapy to short-term healthcare utilization in a managed care population Am J Manage Care 4 1998 1691 1698
22. The R Project for Statistical Computing, http://www.r-project.org/. Accessed 15.03.2005.
23. Gass MLS, R.W. Robert, J.H. Liu, and M.I. Cedars Characteristics of women who discontinue using hormone replacement therapy Menopause 4 1997 19 23
24. Y. Shmuely, J.A. Berlin, J. Knauss, and E. Lydick Compliance with oral HRT in postmenopausal women in clinical trials: meta analysis Maturitas 46 2003 33 44
25. T. Vihtamaki, R. Savilahti, and R. Tuimala Why do postmenopausal women discontinue hormone replacement therapy? Maturitas 33 1999 99 105
26. J.M. Thorp Jr., N.I. Gavin, and R.L. Ohsfeldt Hormone replacement therapy in postmenopausal women: utilization of health care resources by new users Am J Obstet Gynecol 185 2001 318 326
27. P. Eiken, and N. Kolthoff Compliance with 10 years oral hormonal replacement therapy Maturitas 41 2002 81 86
28. T.N. Leung, C.J. Haines, and T.K. Chung Five-year compliance with hormone replacement therapy in postmenopausal Chinese women in Hong Kong Maturitas 39 2001 195 201
29. State Agency of Medicines. Ravimistatistika aastaraamat 2003 (Estonian Statistics on Medicines 2003), http://www.sam.ee/orb.aw/class=file/action = preview/id=1754/Ravimistatistika+aastaraamat+2003.pdf. Accessed 15.03.2005.
30. E. Hemminki, T. Karttunen, S.-L. Hovi, and H. Karro The drug industry and medical practice: the case on menopausal hormone therapy in Estonia Soc Sci Med 58 2004 89 97
31. I. Den Tonkelaar, and B.J. Oddens Determinants of long-term hormone replacement therapy and reasons for early discontinuation Obstet Gynecol 95 2000 507 512
32. Hovi S-L, Veerus P, Karro H, Topo P, Hemminki E. Women's views of climacteric at the time of low menopausal hormone use, Estonia 1998. Maturitas. In press 2005.
33. P.J. Ryan, R. Harrison, G.M. Blake, and I. Fogelman Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis Br J Obstet Gynaecol 99 1992 325 328
34. S. Voss, D. Quail, and A. Dawson A randomised, double-blind trial comparing raloxifene HC1 and continuous combined hormone replacement therapy in postmenopausal women: effects on compliance and quality of life Br J Obstet Gynaecol 109 2002 874 885
35. L.E. Nachtigall Enhancing patient compliance with hormone replacement therapy at menopause Obstet Gynecol 75 Suppl. 4 1990 77 80
36. A. Cano Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre Maturitas 20 1994 91 99
37. C.P. Spencer, A.J. Cooper, and M.I. Whitehead Fortnightly review: management of abnormal bleeding in women receiving hormone replacement therapy BMJ 315 1997 37 42
38. I. Bjorn, and T. Backstrom Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy Maturitas 32 1999 77 86
39. D.F. Archer, and J.H. Pickar Hormone replacement therapy: effect of progestin dose and time since menopause on endometrial bleeding Obstet Gynecol 96 2000 899 905
40. J. Manonai, U. Theppisai, C. Suchartwatnachai, T. Jetsawangsri, and A. Chittacharoen Compliance with hormone replacement therapy in Thai women Maturitas 44 2003 201 205
41. I. Van Seumeren Weight gain and hormone replacement therapy: are women's fears justified? Maturitas 34 Suppl. 1 2000 3 8